Cancer has quietly grown into one of Tanzania's most urgent health challenges. Diagnoses are climbing faster than the country's hospitals can keep up with, and that widening gap is pushing thousands of families to look beyond their own borders for treatment. When they do, the overwhelming choice, time and again, is India. This isn't a passing trend or a handful of word-of-mouth stories; it's a well-documented pattern, backed by physician surveys, patient studies, and hard cost data. Here's the full picture, laid out step by step.

The Scale of the Problem at Home

Cancer is hitting Tanzania hard, and the outcomes are sobering. In a single recent year, the country recorded roughly 45,000 new cancer cases and nearly 30,000 deaths. Do the math on that, and it means about two out of every three people diagnosed do not survive. That ratio - known as the mortality-to-incidence ratio - sits at 0.66, which is very high by global standards.

It's worth pausing on what that number actually tells us. A high mortality-to-incidence ratio doesn't necessarily mean Tanzania's cancers are unusually aggressive or unusual in type. It's a signal about the system around the disease - how early people are diagnosed, how quickly they can start treatment, and how much specialised care is available once they do. In many cases, the biology of the cancer isn't the deciding factor in survival. Access is.

A few more numbers help fill in the picture:

• Incidence rate: about 140 new cases per 100,000 people each year
• Death rate: about 97 per 100,000 people each year
• Projected growth: case numbers are expected to roughly double by 2030

Certain cancers stand out. Cervical cancer is the most common cancer in Tanzania overall, and it's the leading cause of cancer death among women of reproductive age. As of 2020, Tanzania had one of the highest cervical cancer incidence rates anywhere in the world - a statistic that reflects gaps in screening and vaccination as much as anything else. Among men, prostate cancer dominates, accounting for roughly one in three male cancer cases. And childhood cancers are an increasingly urgent concern: the majority of young patients are already at an advanced stage by the time they're diagnosed, which sharply limits treatment options and outcomes.

Consult India's Leading Cancer Specialists Before You Travel

Receive a personalized treatment opinion from experienced oncologists at India's top cancer hospitals.

Consult with Specialist

Talk to Expert

Compounding all of this, Tanzania still doesn't have a nationwide, population-based cancer registry. Without one, it's harder to track patterns, catch cancers early, and plan where resources are needed most. The absence of a registry is both a symptom of an under-resourced system and a contributor to the delays that worsen outcomes.

Why Patients Are Looking Elsewhere

Understanding why so many families choose to travel starts with understanding what's missing at home. Much of Tanzania's specialised cancer care - radiotherapy in particular - is concentrated at a single national referral hospital, which is expected to serve a population of more than 60 million people. That's an enormous burden for one facility to carry, and it shows in every part of the system: radiotherapy machines are booked solid, hospital beds are scarce, and there simply aren't enough clinical oncologists to go around.

It gets more difficult still when you look at advanced treatment options. Robotic surgery, PET-CT-guided precision radiotherapy, targeted drug therapies, and bone marrow transplantation - treatments that are considered standard practice in many parts of the world - remain largely unavailable within the country. For a patient with a complex or advanced cancer, that gap isn't a minor inconvenience. It can be the difference between a treatable disease and one that isn't caught in time for effective treatment.

This is the single biggest driver behind Tanzania's outbound cancer referrals. It isn't that patients don't trust their local doctors, or that Tanzanian physicians lack skill - it's that the infrastructure required for certain treatments simply hasn't been built out yet at the scale the country needs.

India Has Become the Go-To Destination

None of this would matter much if patients were scattering randomly to different countries in search of care. But they're not. The data show a clear and consistent pattern: when Tanzanian patients seek care abroad, they overwhelmingly choose India.

This shows up clearly in peer-reviewed research, not just anecdote. A cross-sectional survey published in JCO Global Oncology asked 52 oncologists and cancer specialists across 17 African countries a simple question: where do you refer patients when they need care abroad? The results were striking:

That last figure is worth sitting with. Ninety-four per cent of surveyed oncologists - physicians across nearly a fifth of the African continent - named India as the country they most commonly send patients to. That's about as close to a consensus as you'll find among medical professionals on any question.

A separate study went a step further, comparing 254 patients who travelled for cancer care - some to Kenya, some to India - and asking what actually drove the decision. Cost came up often: more than 73% of patients cited it as a significant factor. But when researchers ran statistical modelling to see what most strongly predicted the choice, cost wasn't even the top factor. Trust was.

A doctor's recommendation turned out to be the single strongest predictor of a patient choosing India - 66 times more likely than not having that recommendation. Advice from friends or family who'd been through the process themselves was the next strongest factor. In other words, people aren't simply chasing the lowest price. They're following the judgment of the people they trust most: their physicians first, and then their own communities.

That distinction matters. It suggests that India's reputation among Tanzanian patients isn't built primarily on marketing or advertising - it's built on outcomes that doctors have seen firsthand and are willing to stake their professional recommendation on.

What Makes India the Preferred Choice

So, what is it about India specifically that has made it the default option? A combination of factors, each reinforcing the others.

• It's genuinely more affordable - without a drop in quality: India has a large, mature domestic pharmaceutical industry, lower labor and facility costs than Western countries, and intense competition among private hospital chains. Together, these keep prices far below what patients would pay in the US or UK, and importantly, this isn't a matter of older equipment or outdated protocols. Many of the hospitals serving international patients are accredited to international standards.
• The medical infrastructure is genuinely advanced: Robotic surgery, modern linear accelerators for radiotherapy (the kind used in IMRT and IGRT techniques), CyberKnife and Gamma Knife radiosurgery systems, PET-CT imaging, genetic sequencing, and dedicated bone marrow transplant units are all commonly available - and not just at one flagship hospital, but across a network of JCI- and NABH-accredited private facilities.
• Surgeons see an extraordinary volume of cases: Between the domestic population and the steady flow of international patients, individual surgeons in India's major hospitals often accumulate case volumes that would take a comparable specialist elsewhere an entire career to match. For complex, high-risk cancer surgery, that kind of repeated, hands-on experience is one of the biggest predictors of a good outcome.
• There's a support system built specifically around international patients: Major hospitals maintain dedicated international patient departments - teams whose entire job is to help someone arriving from another country navigate the process. That includes multilingual staff, visa assistance, airport transfers, help arranging accommodation, and interpreters for patients who don't speak English. For a family already dealing with the stress of a cancer diagnosis, having that logistical burden handled by someone else makes an enormous difference.
• Care moves quickly: Tanzanian patients frequently report seeing a specialist within 24 to 48 hours of arriving in India - a sharp contrast to the waits they might face for equivalent care at home. This isn't just a convenience. Delayed treatment initiation is directly linked to worse outcomes in cancer care, so the speed at which a patient can move from arrival to an actual treatment plan can meaningfully affect their prognosis.
• Treatment can be split sensibly between countries: A common and increasingly formalised approach is what's sometimes called a shared-care model: the most technical phase of treatment, usually surgery, is performed in India, while a detailed medical protocol allows chemotherapy or follow-up radiotherapy to continue back home under a local oncologist. This reduces the total time and cost a family must spend abroad while still giving the patient access to India's surgical expertise where it matters most.

How Much Cheaper, Really?

The affordability gap between India and Western countries isn't marginal - it's dramatic, often by a factor of five to ten depending on the treatment.

Averaged across treatment types, care in India tends to run 60 to 85 per cent cheaper than equivalent treatment in the US or UK. To put that into a real-world example: a commonly cited case involves a mastectomy combined with six cycles of chemotherapy and 25 sessions of radiation - a fairly standard treatment course for breast cancer. In the US, that combination of treatments can run into six figures. In India, the total cost is often tens of thousands of dollars lower, with total savings sometimes exceeding $150,000 for the most complex, multi-modality cases.

As a general planning benchmark, international patients treating cancer in India typically spend somewhere between $1,500 and $16,000 in total - a range that would barely cover a single round of chemotherapy in the United States, let alone a complete course of treatment.

India's Place in Global Medical Travel

India's role as a cancer treatment hub doesn't exist in isolation - it's part of a much larger medical tourism industry that has grown rapidly over the past decade.

What's notable here is that other popular medical tourism destinations, like Turkey, tend to specialise in cosmetic and elective procedures. India stands out for having built deep infrastructure specifically around serious, high-stakes conditions like cancer and heart disease - the kinds of treatment where quality and outcomes matter more than anywhere else.

Scale isn't just an economic footnote either - it has a direct clinical impact. A higher patient volume means specialists gain more hands-on experience, hospitals can justify investing in newer equipment sooner, and the cost per patient decreases as facilities operate at full capacity. All of that feeds back into the affordability and breadth of treatment that make India attractive in the first place. Within India itself, Chennai has earned the nickname "India's health capital," drawing an estimated 45% of the country's foreign health tourists on its own.

What the Journey Usually Looks Like

For a family considering treatment abroad, it helps to understand what the process actually involves, step by step:

• Diagnosis and referral at home: The process typically begins with a diagnosis at a domestic Tanzanian hospital, often followed by a doctor's recommendation to seek treatment abroad.
• Remote case review: Medical reports and scans are shared with an Indian hospital or a facilitator organisation and are typically reviewed within 24 to 48 hours, giving the family an early sense of the recommended treatment plan and cost before committing to travel.
• Visa processing: Most patients travel using India's e-Medical Visa, a streamlined visa category designed specifically for international patients.
• Travel. Flights are often routed through regional hubs en route to India.
• On-ground diagnostics: Once the patient arrives, hospitals typically repeat key diagnostic tests to confirm the treatment plan before proceeding.
• Treatment delivery: This is the core phase - chemotherapy, radiotherapy, or surgery - carried out with the support of the hospital's international patient team.
• Follow-up and return: After treatment, patients return home with detailed medical reports, allowing a local oncologist to continue monitoring and follow-up care.

Compare Cancer Treatment Costs and India's Best Hospitals

Explore treatment costs and leading NABH & JCI-accredited hospitals

View Cost

Top Hospitals

Chat with Our Healthcare Assistant

Trusted by 100000+ patients and leading medical experts.

Things to Plan For

Travelling abroad for cancer treatment isn't without real challenges, and it's worth being clear-eyed about them rather than treating the decision as a simple bargain.

• Travel costs add up: Flights, visa fees, and accommodation for a caregiver - someone almost always needs to travel with the patient - all sit on top of the treatment quote itself, and families should budget for them from the start.
• Adjusting to a new environment takes time: India's major medical hubs are large, dense, fast-moving cities, which can be a significant adjustment for a patient and family arriving from a very different setting, especially while also managing the stress of treatment.
• Hidden costs are easy to underestimate: Pathology fees, repeat imaging, additional medication, and the possibility of an extended stay if complications arise are all costs that frequently don't show up in the initial treatment estimate.
• Continuity of care requires planning: Once treatment in India is complete and the patient returns home, coordinating ongoing care with a local oncologist takes proactive effort and clear discharge documentation from the treating hospital. Without that handoff being managed carefully, patients risk gaps in their follow-up care.

How MediGence Supports Your Cancer Treatment Journey

• Free Case Review: Share your medical reports and scans for an expert evaluation.
• Personalized Treatment Plan: Receive a verified treatment plan with recommended hospitals and specialists within 48 hours.
• Second Opinion: Get expert oncologist opinions before deciding to travel.
• Transparent Pricing: Receive detailed, pre-negotiated treatment packages with no hidden costs.
• Hospital & Doctor Matching: Get matched with hospitals and specialists based on your diagnosis, treatment outcomes, and expertise.
• Medical Visa Assistance: Support with visa documentation and application guidance.
• Travel & Stay Coordination: Assistance with flights, accommodation, airport transfers, and local logistics.
• Dedicated Case Manager: A single point of contact to coordinate appointments and provide support throughout your treatment.
• On-Ground Patient Support: Help with hospital admissions, interpreter support (if needed), and treatment coordination.
• Post-Treatment Follow-Up: Assistance in sharing medical records, treatment summaries, and follow-up plans with your local oncologist in Tanzania to ensure continuity of care.

The Bottom Line

Put together, physician referral surveys, patient-level case-control studies, and hospital cost data all point in the same direction. India has become the default cross-border destination for Tanzanian cancer patients because it offers a rare combination: deep, modern oncology infrastructure; costs running 60 to 85 percent below Western benchmarks; and a medical tourism system that has been deliberately built around the needs of international patients.

With 94% of surveyed African oncologists naming India as their top referral destination - and with trust in doctors and community networks outweighing even cost as the primary driver of that choice - this is a well-established, well-documented pattern rather than a passing trend. As Tanzania's cancer burden continues to grow faster than domestic treatment capacity can keep pace, India looks likely to remain at the centre of the region's outbound cancer-care corridor for the foreseeable future.